Akouos nabs $50 million Series A
Boston-based Akouos, a precision genetic medicine company, has raised $50 million in Series A financing. The lead investors were 5AM Ventures and New Enterprise Associates. Other investors in the round were Partners Innovation Fund, Sofinnova Ventures, RA Capital Management and Novartis Venture Fund.
7 August 2018•1 min read
